Add to ORKGA 33-year-old woman with a history of chronic transplant dysfunction because of repeated bouts of haemolytic uraemic syndrome (HUS) was considered for a second transplant. Extensive genetic investigation of the complement system was executed to rule out known mutations prone to development of HUS. This case illustrates the importance of genetic screening in patients with recurrent HUS.</p
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
Secondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombotic microangiopathies a...
A 33-year-old woman with a history of chronic transplant dysfunction because of repeated bouts of ha...
A 33-year-old woman with a history of chronic transplant dysfunction because of repeated bouts of ha...
Hemolytic uremic syndrome (HUS) is a disease of microangiopathic hemolytic anemia, thrombocytopenia ...
Complement factor H (CFH)-associated hemolytic uremic syndrome (HUS) is a genetic form of atypical H...
SummaryHemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytop...
Item does not contain fulltextAtypical hemolytic uremic syndrome (HUS) can recur after renal transpl...
International audienceSecondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombot...
Hemolytic uremic syndrome (HUS) is a rare, life threatening disease characterized by thrombocytopeni...
4 p.-1 fig.aHUS is a rare disease characterized by episodes of TMA that frequently progresses to CKD...
There is a significant risk of disease recurrence in patients with diarrhea-negative hemolytic-uremi...
Hemolytic uremic syndrome (HUS) includes a heterogeneous group of hemolytic disorders. Among the ide...
A genetic predisposition involving complement regulatory genes has become evident in some patients w...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
Secondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombotic microangiopathies a...
A 33-year-old woman with a history of chronic transplant dysfunction because of repeated bouts of ha...
A 33-year-old woman with a history of chronic transplant dysfunction because of repeated bouts of ha...
Hemolytic uremic syndrome (HUS) is a disease of microangiopathic hemolytic anemia, thrombocytopenia ...
Complement factor H (CFH)-associated hemolytic uremic syndrome (HUS) is a genetic form of atypical H...
SummaryHemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytop...
Item does not contain fulltextAtypical hemolytic uremic syndrome (HUS) can recur after renal transpl...
International audienceSecondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombot...
Hemolytic uremic syndrome (HUS) is a rare, life threatening disease characterized by thrombocytopeni...
4 p.-1 fig.aHUS is a rare disease characterized by episodes of TMA that frequently progresses to CKD...
There is a significant risk of disease recurrence in patients with diarrhea-negative hemolytic-uremi...
Hemolytic uremic syndrome (HUS) includes a heterogeneous group of hemolytic disorders. Among the ide...
A genetic predisposition involving complement regulatory genes has become evident in some patients w...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
Secondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombotic microangiopathies a...